Paper Details 
Original Abstract of the Article :
INTRODUCTION: In this research, we investigated any possible effect of receiving hyperbaric oxygen therapy (HBOT) or risperidone on the core symptoms of autism in children diagnosed with autism spectrum disorder (ASD). METHODS: This study was a randomized, controlled clinical trial in Minia and Ass...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693815/

データ提供:米国国立医学図書館(NLM)

Hyperbaric Oxygen Therapy and Risperidone for Autism

This randomized clinical trial investigates the effects of hyperbaric oxygen therapy (HBOT) and risperidone on the core symptoms of autism in children diagnosed with autism spectrum disorder (ASD). The study included 180 children with autism aged 5-8 years, divided into three groups: HBOT, risperidone, and a control group. The study found that both HBOT and risperidone were effective in treating the core symptoms of autism. However, HBOT showed better results than risperidone therapy.

A New Hope for Autism Treatment

The findings of this study suggest that HBOT could be a promising non-pharmacologic treatment option for children with autism. This is particularly important, as long-term use of drug therapy in children can lead to side effects and compliance issues.

Hyperbaric Oxygen Therapy: A Breath of Fresh Air

HBOT is a fascinating and promising therapy that involves breathing pure oxygen in a pressurized chamber. HBOT’s potential to improve brain function is an exciting area of research, particularly for conditions like autism.

Dr.Camel's Conclusion

This study provides valuable insights into the potential benefits of HBOT as a treatment for autism. It highlights the importance of exploring non-pharmacologic treatment options for children with autism. The findings suggest that HBOT could offer a safer and more effective alternative to traditional therapies. This research is a step towards a brighter future for children with autism.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-12-06
Further Info :

Pubmed ID

38050572

DOI: Digital Object Identifier

PMC10693815

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.